Nucleus pulposus cells regulate macrophages in degenerated intervertebral discs via the integrated stress response-mediated CCL2/7-CCR2 signaling pathway

Shuo Tian,Xuanzuo Chen,Wei Wu,Hui Lin,Xiangcheng Qing,Sheng Liu,BaiChuan Wang,Yan Xiao,Zengwu Shao,Yizhong Peng
DOI: https://doi.org/10.1038/s12276-024-01168-4
2024-02-06
Experimental & Molecular Medicine
Abstract:Lower back pain (LBP), which is a primary cause of disability, is largely attributed to intervertebral disc degeneration (IDD). Macrophages (MΦs) in degenerated intervertebral discs (IVDs) form a chronic inflammatory microenvironment, but how MΦs are recruited to degenerative segments and transform into a proinflammatory phenotype remains unclear. We evaluated chemokine expression in degenerated nucleus pulposus cells (NPCs) to clarify the role of NPCs in the establishment of an inflammatory microenvironment in IDD and explored the mechanisms. We found that the production of C-C motif chemokine ligand 2 (CCL2) and C-C motif chemokine ligand 7 (CCL7) was significantly increased in NPCs under inflammatory conditions, and blocking CCL2/7 and their receptor, C-C chemokine receptor type 2(CCR2), inhibited the inductive effects of NPCs on MΦ infiltration and proinflammatory polarization. Moreover, activation of the integrated stress response (ISR) was obvious in IDD, and ISR inhibition reduced the production of CCL2/7 in NPCs. Further investigation revealed that activating Transcription Factor 3 (ATF3) responded to ISR activation, and ChIP-qPCR verified the DNA-binding activity of ATF3 on CCL2/7 promoters. In addition, we found that Toll-like receptor 4 (TLR4) inhibition modulated ISR activation, and TLR4 regulated the accumulation of mitochondrial reactive oxygen species (mtROS) and double-stranded RNA (dsRNA). Downregulating the level of mtROS reduced the amount of dsRNA and ISR activation. Deactivating the ISR or blocking CCL2/7 release alleviated inflammation and the progression of IDD in vivo. Moreover, MΦ infiltration and IDD were inhibited in CCR2-knockout mice. In conclusion, this study highlights the critical role of TLR4/mtROS/dsRNA axis-mediated ISR activation in the production of CCL2/7 and the progression of IDD, which provides promising therapeutic strategies for discogenic LBP.
biochemistry & molecular biology,medicine, research & experimental
What problem does this paper attempt to address?
The problem that this paper attempts to solve is: during the process of intervertebral disc degeneration (IDD), how are macrophages (MΦs) recruited to the degenerated area and transformed into a pro - inflammatory phenotype, and what are the specific mechanisms of this transformation. Specifically, the researchers focused on the regulatory effect of nucleus pulposus cells (NPCs) on macrophages through the CCL2/7 - CCR2 signaling pathway mediated by the integrated stress response (ISR). ### Research Background and Problems - **Background**: Low back pain (LBP) is one of the main causes of disability, and approximately 40% of chronic LBP cases are related to intervertebral disc degeneration (IDD). IDD can lead to the destruction of spinal structure and mobility, and ultimately cause pain and loss of function. - **Problem**: In the degenerated intervertebral disc, macrophages form a chronic inflammatory microenvironment, but how macrophages are recruited to the degenerated area and transformed into a pro - inflammatory phenotype, and the specific mechanism of this process is still unclear. ### Research Objectives - **Main Objective**: To explore how nucleus pulposus cells (NPCs) recruit macrophages through the CCL2/7 - CCR2 signaling pathway and promote their transformation into a pro - inflammatory phenotype. - **Specific Questions**: - Do nucleus pulposus cells produce more CCL2 and CCL7 under inflammatory conditions? - Can blocking CCL2/7 and its receptor CCR2 inhibit the recruitment and pro - inflammatory polarization of macrophages by nucleus pulposus cells? - What is the activation state of the integrated stress response (ISR) in IDD? Can ISR inhibition reduce the production of CCL2/7? - Does activating transcription factor 3 (ATF3) respond to ISR activation and participate in the transcriptional regulation of CCL2/7? - Does Toll - like receptor 4 (TLR4) regulate ISR activation, as well as the accumulation of mtROS and dsRNA? ### Research Methods - **Experimental Design**: Through in vitro experiments and animal models, detect the expression of CCL2 and CCL7 in nucleus pulposus cells, evaluate the effects of blocking CCL2/7 and CCR2, and the influence of ISR inhibitors on the production of CCL2/7. - **Molecular Mechanism**: Use RNA - seq and ChIP - qPCR techniques to explore the regulatory mechanism of ISR activation on the expression of CCL2/7, especially the binding activity of ATF3 on the CCL2/7 promoter. ### Main Findings - **Increased CCL2/7 Expression**: Under inflammatory conditions, the expression of CCL2 and CCL7 in nucleus pulposus cells significantly increases. - **Role of the CCL2/7 - CCR2 Axis**: Blocking CCL2/7 and CCR2 can inhibit the recruitment and pro - inflammatory polarization of macrophages by nucleus pulposus cells. - **Activation of ISR**: ISR is significantly activated in IDD, and ISR inhibition can reduce the production of CCL2/7. - **Regulatory Role of ATF3**: ATF3 responds to ISR activation and has DNA - binding activity on the CCL2/7 promoter, participating in the transcriptional regulation of CCL2/7. - **Regulatory Role of TLR4**: TLR4 inhibition can regulate ISR activation, thereby affecting the accumulation of mtROS and dsRNA. ### Conclusions - **Key Mechanism**: The TLR4/mtROS/dsRNA - axis - mediated ISR activation plays a key role in the production of CCL2/7 and the progression of IDD. - **Treatment Strategy**: These findings provide new targets and strategies for the treatment of discogenic low back pain. Through these studies, the authors have revealed the specific mechanism by which nucleus pulposus cells recruit and polarize macrophages through the CCL2/7 - CCR2 signaling pathway in IDD, providing an important theoretical basis for future research and clinical applications.